Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:11 pm Purchase |
2024-09-30 | 13G | AbCellera Biologics Inc. ABCL |
Baker Bros. Advisors LP | 27,525,640 9.300% |
4,615,887 (+20.15%) |
Filing History |
| 2024-10-09 10:20 am Sale |
2024-09-30 | 13G | AbCellera Biologics Inc. ABCL |
BAILLIE GIFFORD & CO | 12,894,703 4.400% |
-11,150,093 (-46.37%) |
Filing History |
| 2024-02-14 4:21 pm Purchase |
2023-12-31 | 13G | AbCellera Biologics Inc. ABCL |
Baker Bros. Advisors LP | 22,909,753 7.900% |
22,909,753 (New Position) |
Filing History |
| 2024-02-13 5:01 pm Purchase |
2023-12-31 | 13G | AbCellera Biologics Inc. ABCL |
Hansen Carl L. G. | 60,740,524 20.600% |
1,747,217 (+2.96%) |
Filing History |
| 2024-01-29 11:47 am Purchase |
2023-12-29 | 13G | AbCellera Biologics Inc. ABCL |
BAILLIE GIFFORD & CO | 24,044,796 8.290% |
4,348,061 (+22.08%) |
Filing History |
| 2023-04-24 4:53 pm Unchanged |
2023-04-24 | 13D | AbCellera Biologics Inc. ABCL |
THIEL PETER | 14,360,427 4.990% |
0 (Unchanged) |
Filing History |
| 2023-02-13 2:49 pm Sale |
2023-02-14 | 13G | AbCellera Biologics Inc. ABCL |
Capital World Investors | 9,327,493 3.300% |
-12,724,210 (-57.70%) |
Filing History |
| 2023-02-06 4:31 pm Purchase |
2022-12-31 | 13G | AbCellera Biologics Inc. ABCL |
Hansen Carl L. G. | 58,993,307 20.400% |
3,586,608 (+6.47%) |
Filing History |
| 2023-01-18 06:35 am Purchase |
2022-12-30 | 13G | AbCellera Biologics Inc. ABCL |
BAILLIE GIFFORD & CO | 19,696,735 6.880% |
19,696,735 (New Position) |
Filing History |
| 2022-02-14 5:01 pm Sale |
2021-12-31 | 13G | AbCellera Biologics Inc. ABCL |
VIKING GLOBAL INVESTORS LP | 0 0.000% |
-19,283,744 (Position Closed) |
Filing History |
| 2022-02-14 3:24 pm Sale |
2021-12-31 | 13G | AbCellera Biologics Inc. ABCL |
DCVC Bio L.P. | 7,305,761 2.600% |
-21,800,000 (-74.90%) |
Filing History |
| 2022-02-11 2:48 pm Purchase |
2022-02-14 | 13G | AbCellera Biologics Inc. ABCL |
Capital World Investors | 22,051,703 7.800% |
22,051,703 (New Position) |
Filing History |
| 2022-02-10 4:30 pm Sale |
2021-12-31 | 13G | AbCellera Biologics Inc. ABCL |
Hansen Carl L. G. | 55,406,699 19.500% |
-6,421,131 (-10.39%) |
Filing History |
| 2021-02-16 4:18 pm Purchase |
2020-12-31 | 13G | AbCellera Biologics Inc. ABCL |
Hansen Carl L. G. | 61,827,830 23.000% |
61,827,830 (New Position) |
Filing History |
| 2021-02-12 8:00 pm Unchanged |
2020-12-31 | 13G | AbCellera Biologics Inc. ABCL |
VIKING GLOBAL INVESTORS LP | 19,283,744 7.200% |
0 (Unchanged) |
Filing History |
| 2021-02-09 06:24 am Purchase |
2020-12-31 | 13G | AbCellera Biologics Inc. ABCL |
DCVC Bio L.P. | 29,105,761 10.800% |
29,105,761 (New Position) |
Filing History |
| 2020-12-28 4:48 pm Purchase |
2020-12-15 | 13D | AbCellera Biologics Inc. ABCL |
THIEL PETER | 14,360,427 5.300% |
14,360,427 (New Position) |
Filing History |
| 2020-12-23 8:37 pm Unchanged |
2020-12-14 | 13G | AbCellera Biologics Inc. ABCL |
VIKING GLOBAL INVESTORS LP | 19,283,744 7.200% |
0 (Unchanged) |
Filing History |
| 2020-12-21 5:28 pm Purchase |
2020-12-14 | 13G | AbCellera Biologics Inc. ABCL |
VIKING GLOBAL INVESTORS LP | 19,283,744 7.200% |
19,283,744 (New Position) |
Filing History |